Background: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary disease
(COPD) and it has important clinical implications, such as reduced exercise tolerance …

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability
internationally. Alveolar hypoxia and consequent hypoxemia increase in prevalence as …

Since the last statements on pulmonary rehabilitation by the American Thoracic Society
(ATS; 1999) and the European Respiratory Society (ERS; 1997), there have been numerous …

Respiratory and/or limb muscle dysfunction, which are frequently observed in chronic
obstructive pulmonary disease (COPD) patients, contribute to their disease prognosis …

In patients with pulmonary disease, disease severity and prognosis are determined not only
by lung function impairment (1, 2). In patients with mild, moderate, or severe disease …

Muscle dysfunction often occurs in patients with chronic obstructive pulmonary disease
(COPD) and may involve both respiratory and locomotor (peripheral) muscles. The loss of …

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

The natural course of chronic obstructive pulmonary disease (COPD) is complicated by the
development of systemic consequences and co-morbidities. These may be major features in …

In the next decade, Chronic Obstructive Pulmonary Disease (COPD) will be a major leading
cause of death worldwide. Impaired muscle function and mass are common systemic …

Chronic obstructive pulmonary disease (COPD) is a debilitating disease characterized by
inflammation-induced airflow limitation and parenchymal destruction. In addition to …